The mortality rate from influenza in the United States is by far highest among those aged 65 years and older. During the 2023-2024 flu season, the mortality rate from influenza for this age group was around 32.1 per 100,000 population. The burden of influenza The impact of influenza in the U.S. varies from season to season, but in the 2023-2024 flu season, there were an estimated 40 million cases. These cases resulted in around 470,000 hospitalizations. Although most people recover from influenza without requiring medical treatment, the disease can be deadly for young children, the elderly, and those with weakened immune systems or chronic illnesses. During the 2023-2024 flu season, around 28,000 people in the U.S. lost their lives due to influenza. Impact of vaccinations The most effective way to prevent influenza is to receive an annual vaccination at the beginning of flu season. Flu vaccines are safe and can greatly reduce the burden of the disease. During the 2022-2023 flu season, vaccinations prevented around 2,479 deaths among those aged 65 years and older. Although flu vaccines are usually cheap and easily accessible, every year a large share of the population in the U.S. still does not get vaccinated. For example, during the 2022-2023 flu season, only about 35 percent of those aged 18 to 49 years received a flu vaccination.
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
The graph illustrates the number of flu-related deaths in the United States for each flu season from 2010-2011 to 2023-2024*. The x-axis represents the flu seasons, labeled from '10-11 to '23*-24*, while the y-axis shows the annual number of flu deaths. Throughout this period, flu deaths vary significantly, ranging from a low of 4,900 in the 2021-2022* season to a high of 51,000 in both the 2014-2015 and 2017-2018 seasons. Other notable figures include 36,000 deaths in 2010-2011, 42,000 in 2012-2013, and a recent increase to 28,000 in the 2023*-2024* season. The data exhibits considerable fluctuations with no consistent upward or downward trend, highlighting the variability in flu mortality rates over the years. This information is presented in a line graph format, effectively showcasing the yearly changes and peaks in flu-related deaths across the United States.
*Data for the 2021-2022 and 2022-2023 seasons are estimated.
The burden of influenza in the United States can vary from year to year depending on which viruses are circulating, how many people receive an influenza vaccination, and how effective the vaccination is in that particular year. During the 2023-2024 flu season, around 28,000 people lost their lives to the disease. Although most people recover from influenza without needing medical care, the disease can be deadly among young children, the elderly, and those with weakened immune systems or chronic illnesses. Deaths due to influenza Even though most people recover from influenza without medical care, influenza and pneumonia can be deadly, especially for older people and those with certain preexisting conditions. Influenza is a common cause of pneumonia and although most cases of influenza do not develop into pneumonia, those that do are often more severe and more deadly. Deaths due to influenza are most common among the elderly, with a mortality rate of around 32 per 100,000 population during the 2023-2024 flu season. In comparison, the mortality rate for those aged 50 to 64 years was 9.1 per 100,000 population. Flu vaccinations The most effective way to prevent influenza is to receive an annual influenza vaccination. These vaccines have proven to be safe and are usually cheap and easily accessible. Nevertheless, every year a large share of the population in the United States still fails to get vaccinated against influenza. For example, in the 2022-2023 flu season, only 35 percent of those aged 18 to 49 years received a flu vaccination. Unsurprisingly, children and the elderly are the most likely to get vaccinated. It is estimated that during the 2022-2023 flu season, vaccinations prevented over 929 thousand influenza cases among children aged 6 months to 4 years.
Official statistics are produced impartially and free from political influence.
In 2021, there were four death cases caused by the influenza virus in China. The death rate of the virus amounted to approximately 0.0003 out of ten million people. Influenza, commonly known as "flu", is a highly contagious respiratory disease caused by influenza A or B viruses and can be prevented by vaccines. It should be noted that the Chinese health authorities calculate death cases for infectious diseases differently, counting only patients who died directly from the infectious disease.
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Australia Influenza Mortality jumped by 8% in 2019, from a year earlier.
This file contains the provisional percent of total deaths by week for COVID-19, Influenza, and Respiratory Syncytial Virus for deaths occurring among residents in the United States. Provisional data are based on non-final counts of deaths based on the flow of mortality data in National Vital Statistics System.
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Forecast: Influenza Mortality in Japan 2023 - 2027 Discover more data with ReportLinker!
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretabilty. We also formatted the data into a standard data format.
Each Project Tycho dataset contains case counts for a specific condition (e.g. measles) and for a specific country (e.g. The United States). Case counts are reported per time interval. In addition to case counts, datsets include information about these counts (attributes), such as the location, age group, subpopulation, diagnostic certainty, place of aquisition, and the source from which we extracted case counts. One dataset can include many series of case count time intervals, such as "US measles cases as reported by CDC", or "US measles cases reported by WHO", or "US measles cases that originated abroad", etc.
Depending on the intended use of a dataset, we recommend a few data processing steps before analysis:
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 14 July 2022 to 6 July 2023.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
Official statistics are produced impartially and free from political influence.
This file contains the complete set of data reported to 122 Cities Mortality Reposting System. The system was retired as of 10/6/2016. While the system was running each week, the vital statistics offices of 122 cities across the United States reported the total number of death certificates processed and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group (Under 28 days, 28 days - 1 year, 1-14 years, 15-24 years, 25-44 years, 45-64 years, 65-74 years, 75-84 years, and - 85 years). U:Unavailable. - : No reported cases.* Mortality data in this table were voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included. Total includes unknown ages. More information on Flu Activity & Surveillance is available at http://www.cdc.gov/flu/weekly/fluactivitysurv.htm.
No description provided
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Forecast: Influenza Mortality in the US 2022 - 2026 Discover more data with ReportLinker!
https://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
this graph was created in OurDataWorld, R , Loocker and Tableau
https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Fcae3bb501c71af31a491739671842d0d%2Fgraph1.png?generation=1712001396965624&alt=media" alt="">
https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Fb9bb57abd368d522f4f70edd77e44cd5%2Fgraph2.png?generation=1712001404173500&alt=media" alt="">
https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Ffcc4718729d85efd4fb21eb4cdfb1ee3%2Fgraph3.jpg?generation=1712001411161330&alt=media" alt="">
https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2F3a1dd72755f5473cf5f9c0758edc1dd3%2Fgraph4.png?generation=1712001416526151&alt=media" alt="">
Introduction: Seasonal influenza, often perceived as a common illness, carries a significant global burden, claiming hundreds of thousands of lives annually. Despite advancements in healthcare and vaccination efforts, the flu remains a formidable threat, particularly affecting vulnerable populations such as infants and the elderly. This article delves into the intricacies of influenza-related mortality, examining regional disparities, contributing factors, and the implications for public health.
The Global Landscape of Influenza Mortality: Data from the Global Pandemic Mortality Project II sheds light on the magnitude of influenza-related deaths, drawing from surveillance metrics spanning from 2002 to 2011. These estimates, while informative, underscore the challenge of accurately gauging mortality rates, especially in low-income countries where testing and mortality records may be lacking.
Respiratory Symptoms and Beyond: The conventional understanding of influenza-related fatalities primarily revolves around respiratory complications. Pneumonia and other respiratory ailments serve as prominent causes of death, contributing to the staggering toll of 400,000 lives claimed annually. However, it is imperative to acknowledge that the impact of influenza extends beyond respiratory symptoms. Complications such as strokes and heart attacks, though not explicitly captured in mortality estimates, further amplify the disease's lethality, warranting comprehensive preventive measures.
Vulnerability Across Age Groups: Influenza's lethality is not uniform across age demographics. Infants and the elderly emerge as the most susceptible cohorts, bearing the brunt of severe complications and mortality. Among individuals aged over 65, the mortality rate stands at approximately 31 per 100,000 in Europe alone, reflecting the disproportionate impact on older populations. The interplay of age-related factors, including weakened immune responses and underlying health conditions, exacerbates the severity of influenza outcomes among these groups.
Regional Disparities and Determinants: A notable aspect of influenza mortality lies in its disparate distribution across regions. While Europe and North America exhibit relatively lower death rates, countries in South America, Africa, and South Asia grapple with higher mortality burdens. This regional divide underscores the complex interplay of socio-economic factors, healthcare accessibility, and vaccination coverage. Poverty, inadequate healthcare infrastructure, and suboptimal vaccination rates converge to heighten vulnerability to influenza-related complications, amplifying mortality rates in resource-constrained settings.
Implications for Public Health: The revelation of significant regional differentials in influenza mortality necessitates a tailored approach to public health interventions. Strengthening healthcare systems, particularly in low-income regions, is paramount to bolstering surveillance, enhancing diagnostic capabilities, and facilitating timely interventions. Furthermore, targeted vaccination campaigns, coupled with education initiatives, hold promise in mitigating influenza's toll, especially among vulnerable populations. Addressing socio-economic disparities and bolstering healthcare resilience emerge as pivotal strategies in fortifying global defenses against seasonal influenza.
Conclusion: Seasonal influenza, often underestimated in its impact, exacts a substantial toll on global health each year. The multifaceted nature of influenza-related mortality underscores the need for a nuanced understanding and comprehensive mitigation strategies. By addressing regional disparities, prioritizing vulnerable populations, and fortifying healthcare systems, the global community can strive towards mitigating the burden of seasonal influenza, safeguarding lives, and fostering resilient health systems for generations to come.
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Monthly Cumulative Number and Percent of Persons Who Receive ≥1 Influenza Vaccination Doses and Comparison Between 2023-2024 and Two Previous Seasons, by Jurisdiction, United States
• Influenza vaccination coverage for children and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. More information about the IIS can be found at https://www.cdc.gov/vaccines/programs/iis/about.html.
• Influenza vaccination coverage estimate numerators include the number of people receiving at least one dose of influenza vaccine in a given flu season, based on information that state, territorial, and local public health agencies report to CDC. Some jurisdictions’ data may include data submitted by tribes. Estimates include persons who are deceased but received a vaccination during the current season. People receiving doses are attributed to the jurisdiction in which the person resides unless noted otherwise. Quality and completeness of data may vary across jurisdictions. Influenza vaccination coverage denominators are obtained from 2020 U.S. Census Bureau population estimates.
• Monthly estimates shown are cumulative, reflecting all persons vaccinated from July through a given month of that flu season. Cumulative estimates include any historical data reported since the previous submission. National estimates are not presented since not all U.S. jurisdictions are currently reporting their IIS data to CDC. Jurisdictions reporting data to CDC include U.S. states, some localities, and territories.
• Because IIS data contain all vaccinations administered within a jurisdiction rather than a sample, standard errors were not calculated and statistical testing for differences in estimates across years were not performed.
• Laws and policies regarding the submission of vaccination data to an IIS vary by state, which may impact the completeness of vaccination coverage reflected for a jurisdiction. More information on laws and policies are found at https://www.cdc.gov/vaccines/programs/iis/policy-legislation.html.
• Coverage estimates based on IIS data are expected to differ from National Immunization Survey (NIS) estimates for children (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-coverage-race.html)
and adults (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-adult-coverage.html) because NIS estimates are based on a sample that may not be representative after survey weighting and vaccination status is determined by survey respondent rather than vaccine records or administrations, and quality and completeness of IIS data may vary across jurisdictions. In general, NIS estimates tend to overestimate coverage due to overreporting and IIS estimates may underestimate coverage due to incompleteness of data in certain jurisdictions.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses in England.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 18 July 2024 to the present.
Please note that after the week 21 report (covering data up to week 20), this surveillance report will move to a condensed summer report and will be released every 2 weeks.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
View the pre-release access list for these reports.
Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.
Following the outbreak of the H1N1 influenza pandemic of 1918, which came to be known as the Spanish Flu, the number of deaths due to influenza and pneumonia soared. Pneumonia was caused either by the influenza or by a bacterial superinfection that took hold due to the patient's weakened state as a result of the influenza, for this reason, influenza deaths and pneumonia deaths were recorded together as one. Pennsylvania had the highest mortality rate due to the pandemic, where there were over 880 fatalities per 100,000 people; meaning that approximately 0.9 percent of the state's population died from the Spanish Flu pandemic in 1918.
When compared with the 1915 mortality rates, many states, such as California and Pennsylvania, saw their mortality rate due to influenza and pneumonia increase five-fold by 1818, which was the worst year of the pandemic. While the mortality rate decreased significantly in the year 1919, there was no US state where it fell to it's pre-pandemic level, and the 1919 mortality rate was still double the pre-pandemic rate in some states such as California, South Carolina and Washington.
Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
License information was derived automatically
Global Influenza Mortality Share by Country (Units (Male Deaths)), 2023 Discover more data with ReportLinker!
Influenza and pneumonia caused around 10.9 deaths in the U.S. per 100,000 population in 2023. Influenza, or the flu, is a viral infection that is highly contagious and especially common in the winter season. Influenza is a common cause of pneumonia, although most cases of the flu do not develop into pneumonia. Pneumonia is an infection or inflammation of the lungs and is particularly deadly among young children and the elderly. Influenza cases Influenza is very common in the United States, with an estimated 40 million cases reported in 2023-2024. Common symptoms of the flu include cough, fever, runny or stuffy nose, sore throat and headache. Symptoms can be mild but can also be severe enough to require medical attention. In 2023-2024, there were around 18 million influenza-related medical visits in the United States. Prevention To prevent contracting the flu, people can take everyday precautions such as regularly washing their hands and avoiding those who are sick, but the best way to prevent the flu is by receiving the flu vaccination every year. Receiving a flu vaccination is especially important for young children and the elderly, as they are most susceptible to flu complications and associated death. In 2024, around 70 percent of those aged 65 years and older received a flu vaccine, while only 33 percent of those aged 18 to 49 years had done so.
The mortality rate from influenza in the United States is by far highest among those aged 65 years and older. During the 2023-2024 flu season, the mortality rate from influenza for this age group was around 32.1 per 100,000 population. The burden of influenza The impact of influenza in the U.S. varies from season to season, but in the 2023-2024 flu season, there were an estimated 40 million cases. These cases resulted in around 470,000 hospitalizations. Although most people recover from influenza without requiring medical treatment, the disease can be deadly for young children, the elderly, and those with weakened immune systems or chronic illnesses. During the 2023-2024 flu season, around 28,000 people in the U.S. lost their lives due to influenza. Impact of vaccinations The most effective way to prevent influenza is to receive an annual vaccination at the beginning of flu season. Flu vaccines are safe and can greatly reduce the burden of the disease. During the 2022-2023 flu season, vaccinations prevented around 2,479 deaths among those aged 65 years and older. Although flu vaccines are usually cheap and easily accessible, every year a large share of the population in the U.S. still does not get vaccinated. For example, during the 2022-2023 flu season, only about 35 percent of those aged 18 to 49 years received a flu vaccination.